The Future of Addiction Treatment: Precision Medicine, Artificial Intelligence and Digital Technologies
Keywords:
Addiction treatment, Precision medicine, Artificial intelligence, Digital technologyAbstract
Addiction treatment is a complex, multidimensional public health issue; consequently, the concepts of Precision and Personalized Medicine have gained significant importance. These approaches utilize genetic data and brain imaging to stratify patients and select treatment modalities that precisely target underlying pathologies. Examples include OPRM1 gene testing to predict medication response, or using MRI and PET scans to evaluate the brain's reward system. This facilitates the selection of psychosocial interventions, such as Cognitive Behavioral Therapy (CBT), that are tailored to the individual. Furthermore, Artificial Intelligence (AI) plays a role in every stage of care, from screening, diagnosis, and risk prediction in vulnerable populations, to real-time monitoring of vital signs and behaviors via wearable devices, as well as big data analysis for public health policy formulation. Meanwhile, digital technologies such as Virtual Reality (VR) simulate scenarios to reduce cravings, while Digital Therapeutics enhance treatment adherence and reduce dropout rates. However, despite the high potential of these technologies, it is crucial to prioritize safety standards and data privacy. Modern addiction treatment, therefore, aims to integrate biological data with digital technologies and AI to enhance treatment efficacy and ensure long-term sustainability.
References
1. Asyyed S. Precision medicine in addiction treatment: A new era of personalized care. J Addict Res Ther. 2024;15(8):1000687. doi:10.4172/2155-6105.100687.
2. Guerrin CGJ, Tesselaar DRM, Booij J, Schellekens AFA, Homberg JR. Precision medicine in substance use disorders: Integrating behavioral, environmental, and biological insights. Neurosci Biobehav Rev. 2025;176:106311.
doi:10.1016/j.neubiorev.2025.106311.
3. Boness CL, Witkiewitz K. Precision medicine in alcohol use disorder: Mapping etiologic and maintenance mechanisms to mechanisms of behavior change to improve patient outcomes. Exp Clin Psychopharmacol. 2023;31(4):769–79.
doi:10.1037/pha0000613.
4. Kuhlemeier A, Desai Y, Tonigan A, Witkiewitz K, Jaki T, Hsiao YY, et al. Applying methods for personalized medicine to the treatment of alcohol use disorder. J Consult Clin Psychol. 2021;89(4):288–300.
doi:10.1037/ccp0000634.
5. Lohoff FW. Pharmacotherapies and personalized medicine for alcohol use disorder: A review. Pharmaco-genomics. 2020;21(15):1117–38.
doi:10.2217/pgs-2020-0079.
6. Khakpaki A, Sepehri H. AI in addiction: Harnessing technology for diagnosis, prevention, and recovery: A narrative review. Addict Subst Abuse. 2025;3(1):1–7.
7. Suva M, Bhatia G. Artificial intelligence in addiction: Challenges and opportunities. Indian J Psychol Med. 2024;XX(x):1–5.
doi:10.1177/02537176241274148
8. Baird A, Cheng Y, Xia Y. Use of machine learning to examine disparities in completion of substance use disorder treatment. PLoS One. 2022;17(9):e0275054.
9. Wilkinson CS, Lujan MA, Hales C, Costa KM, Fiore VG, Knackstedt LA, et al. Listening to the data: Computational approaches to addiction and learning. J Neurosci. 2023;43(45):7547–53.
doi: 10.1523/JNEUROSCI.1415-23.2023.
10. Qaurooni D, Herr BW, Zappone SR, Wojciechowska K, Borner K, Schleyer T. Visual analytics for data-driven understanding of the substance use disorder epidemic. Inquiry. 2024;61:1–13.
doi: 10.1177/00469580241227020.
11. Sadeghi N, Mousavinasab ES, Sharifi E, Ghoreishi FS, Omidi A. The effect of aversive therapy using virtual reality on craving, depression, and self-efficacy: A pilot study in patients under methadone maintenance treatment. Brain Behav. 2025;15:e70953.
12. Glavak-Tkalić R, Šimunović M, Perić Pavišić K, Razum J, Colombo D. Virtual reality in prevention and treatment of substance-related disorders: A systematic review of randomized controlled trials. Clin Psychol Psychother. 2025;32:e70144.
13. Hao W, Wang X, Li D, Wang G. Overview of the expert consensus on digital therapeutics in addictive-related disorders. Gen Psychiatry. 2024;37:e101392.
14. Lim SH, Shin JK, Ahn ME, Lee CH, Lee SK. The effects of CBT-based digital therapeutic intervention on patients with alcohol use disorder. Front Psychiatry. 2025;16:1486338.
15. Matthews S, Greco A, Rastelli C, Bassir Nia A. Virtual reality and psychedelics: New perspectives and new possibilities in the treatment of alcohol use disorder. Front Psychiatry. 2025;16:1448043.
16. Lu P, Qiu J, Huang S, Wang X, Han S, Zhu S, et al. Interventions for digital addiction: Umbrella review of meta-analyses. J Med Internet Res. 2025;27:e59656.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Journal of Addiction Research and Academic Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
This article is published under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0), which allows others to share the article with proper attribution to the authors and prohibits commercial use or modification. For any other reuse or republication, permission from the journal and the authors is required.
